Avstera Therapeutics Corp.

Pharmaceutical company · Malvern, Pennsylvania, United States

Avstera Therapeutics Corp. is a pharmaceutical company headquartered in Malvern, Pennsylvania, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Avstera Therapeutics at a glance

Typepharmaceutical company

HeadquartersMalvern, Pennsylvania, United States

Earliest incorporation on record2020

SEC CIK1878281

What does Avstera Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $5 million sold (2023).

Frequently asked questions about Avstera Therapeutics

Where is Avstera Therapeutics headquartered?

Avstera Therapeutics Corp. is headquartered in Malvern, Pennsylvania, United States.

What does Avstera Therapeutics do?

Avstera Therapeutics Corp. is a pharmaceutical company.

When was Avstera Therapeutics founded?

The earliest incorporation on record for Avstera Therapeutics Corp. is in 2020, according to public company registers.

Similar companies

Galera Therapeutics, Inc.Malvern, Pennsylvania, United States
PhaseBio Pharmaceuticals IncMalvern, Pennsylvania, United States
Annovis Bio, Inc.Malvern, Pennsylvania, United States
Venatorx Pharmaceuticals, Inc.Malvern, Pennsylvania, United States
Endo LPMalvern, Pennsylvania, United States
Baudax Bio, Inc.Malvern, Pennsylvania, United States
Scilex Pharmaceuticals Inc.Malvern, Pennsylvania, United States
Endo Health Solutions Inc.Malvern, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences